| INTRODUCTION
B cells are traditionally known for their effector function; they are involved in antigen presentation and antibody secretion, conferring humoral immunity upon their differentiation into plasmablasts and plasma cells. However, increasing attention has been directed to the immune regulatory function of B cells. 1 This regulatory function is associated with their production of anti-inflammatory cytokines, such as IL-35, TGF-β and, in particular, IL-10. 2 Previous studies have shown that Breg cells, through the production of IL-10, suppress pathogenic T cells and inhibit autoimmune inflammatory diseases such as arthritis, experimental autoimmune encephalomyelitis (EAE) and colitis, as well as contact hypersensitivity. [3] [4] [5] Moreover, Breg cell transfer can effectively reverse autoimmune diseases in murine models, such as mice with experimental collagen-induced arthritis (CIA) and lupus-prone mice. 6, 7 However, the current understanding of the mechanisms of Breg expression and production of IL-10 remains rudimentary. A recent study revealed that IL-10 and the proto-oncogene c-Maf induced their mutual expression in inflammatory macrophages and that c-Maf was a strong suppressor of IL-12 p40 gene transcription. 8 
c-Maf belongs
to the AP-1 family of basic region/leucine zipper factors and exerts its transcriptional role by binding to a Maf recognition element (MARE). The cell lineage-specific targets of c-Maf have been identified. It was reported that c-Maf regulated IL-10 production in CD4 + T cells in in vivo disease models involving Th1 cells, 9 Th2 cells, 10 Treg cells 11 and Th17 cells. 12 In this study, we further investigated the function of c-Maf in the expression of IL-10 in Breg cells. Experimental evidence supports the concept that Breg cells are not lineage-specific but are instead expanded in response to stimuli. 2 In vitro stimulation via lipopolysaccharide (LPS), together with PMA and ionomycin, induces the differentiation and enrichment of IL-10-producing B cells. Hence, LPS-stimulated B cells were used to explore whether c-Maf played a critical role in the IL-10 expression of B cells in vitro. IL-10-producing Bregs are reported to be quantitatively and functionally altered in a mouse arthritis model and in patients with active rheumatoid arthritis (RA) (reduction in their capacity both to induce Treg from CD4 + and to prevent the conversion of Treg into Th17 cells). 13, 14 However, there are few reports about the regulation of Bregs in RA.
To address this issue, the collagen-induced arthritis (CIA) mouse model was chosen in this study. CIA model is widely used in studying human arthritis because it shows changes similar to those observed in human RA. 15, 16 In this study, we found that c-Maf expression was upregulated in B cells after LPS stimulation, followed by an increase in IL-10 levels. Chromatin immunoprecipitation (ChIP) assays showed that c-Maf could bind to the IL-10 promoter. Knockdown of c-Maf effectively decreased Breg cell production by downregulating IL-10 expression. Interestingly, c-Maf expression was positively associated with IL-10 expression in B cells from a mouse CIA model. Our data suggested that c-Maf could promote the production of IL-10 + Breg cells by increasing IL-10 expression.
| METHODS

| Mice and reagents
Seven-to nine-week-old C57BL/6 mice were purchased from the Hubei Provincial Center for Disease Control and Prevention (Wuhan, China). For the CIA model, the mice were maintained in an SPF environment in the centre for animal experimentation of Wuhan University. The care, use and treatment of the mice in this study were in strict agreement with international guidelines for the care and use of laboratory animals. This study was approved by the Animal Ethics Committee of Medical School of Wuhan University.
| Arthritis model
The CIA models were established as described previously. 15 Chicken CII was diluted in 0.05 mol/L glacial acetic acid to a concentration of 2 mg/mL in 4°C overnight and was then emulsified in equal volumes of CFA. The mice were injected with 100 μL emulsified CII in CFA (CII + CFA) at the base of the tails. On day 21, the mice were given another 100 μL CII + IFA as a booster at the base of the tails. From day 25, paws of the mice gradually developed erythema, swelling or joint rigidity. When the articular index (AI) score was >4 and the volume of unilateral lateral ankle was >1.6, the CIA model was considered to be successfully established. The AI was assessed on a scale of 0-3 based on the severity of arthritis: 0 = normal; 1 = mild swelling with or without erythema with no joint deformity; 2 = severe swelling with no joint deformity; and 3 = joint deformities and joint rigidity. 15 The maximum AI was 12 points, which was the sum of four paws. On day 35, the mice were sacrificed, and the hindlimbs, spleen and lymph nodes (LN) were harvested for further experiments.
Collagen II (CII), complete Freund's adjuvant (CFA) and incomplete Freund's adjuvant (IFA) were purchased from Sigma (St. Louis, MO, USA).
| Histopathological analysis
The hindlimbs of CIA mice and control mice (n = 12 for each) were harvested and fixed in 10% formalin for 24-48 hours, followed by decalcifying in EDTA. The hindlimbs were stained with haematoxylin and eosin (H&E).
| In vitro B cell cultures
Lymphocytes were separated from spleen or lymph nodes (LN) using Ficoll separation solution. B220 + B cells were isolated using mouse B220 MicroBeads (AutoMACS; Miltenyi Biotec, Bergisch Gladbach, Germany) following the manufacturer's instructions and cultured in RPMI-1640 medium containing 10% foetal bovine serum, 2 mmol/L glutamine, penicillin (100 IU/mL), streptomycin (100 mg/ mL) and 50 mmol/L 2-mercaptoethanol. Cells were stimulated for the indicated times with 1 μg/mL lipopolysaccharide (LPS, Sigma L2630 from Escherichia coli 0111:B4; Sigma).
| Cytometric analysis and intracellular cytokine staining
To visualize IL-10-competent B cells, the cells were stimulated with LPS for the indicated time. Before the cells were stained for cell surface B220, 50 ng/mL PMA, 1 μg/mL ionomycin (Sigma), 10 μg/mL brefeldin A and 2 μmol/L monensin were added into the cell culture. After 4 hours, cells were collected and washed with fluorescence-activated cell-sorting staining buffer (PBS, 2% foetal bovine serum or 1% bovine serum albumin, 01% sodium azide). All samples were incubated with anti-Fc receptor antibody (BD Biosciences, Franklin Lakes, NJ, USA) before incubation, with other antibodies diluted in fluorescence-activated cell-sorting buffer supplemented with 2% anti-Fc receptor antibody. After staining for cell surface B220, the cells were fixed for 30 minutes with 1 mL fixation buffer (eBioscience, San Diego, CA, USA). After washing, the fixed cells were stained for IL-10. The samples were filtered immediately before analysis or cell sorting to remove any clumps. The following antibodies were purchased from eBioscience: peridinin-chlorophyll-protein-or allophycocyanin-conjugated anti-mouse B220 antibodies, phycoerythrin-conjugated anti-mouse IL-10 antibodies and phycoerythrin-conjugated Rat IgG1 kappa isotype control. Data collection and analyses were performed on a FACSCalibur flow cytometer using CellQuest software (BD Biosciences, San Jose, CA, USA). All experiments were performed at least three separate times.
| Quantitative RT-PCR analysis
All RNA samples were DNA-free. The cDNA synthesis and quantitative PCR (qPCR) analyses were performed as follows: total RNA was extracted from B cells with TRIzol (Invitrogen Life Technologies, Carlsbad, CA, USA). The final RNA pellets were dissolved in 0.1 mmol/L EDTA (2 μL/mg original wet weight). Reverse transcription reactions were carried out on 22 μL of sample using SuperScript II RNase H-Reverse Transcriptase (Invitrogen Life Technologies) in a reaction volume of 40 μL. All samples were diluted in 160 μL nuclease-free water. Quantitative PCR was employed to quantify mouse c-Maf gene expression from the cDNA samples. Mouse c-Maf primers were designed using PRIMER EXPRESS version 1.0 software (Applied Biosystems, Foster City, CA, USA) from mouse c-Maf gene sequences (GenBank/EBML databases). The primer pair used for qPCR analysis spanned at least one intron. The c-Maf fragment was amplified using the following primers: forward 5′ TGG AGA TCT CCT GCT TGA GG 3′, reverse 5′ AGC AGT TGG TGA CCA TGT CG 3′. The primers for GAPDH were as follows: forward 5′ ACCACAGTCCATGCCATCAC 3′, reverse 5′ TCCACCACCCTGTTGCTGTA 3′. PCR was conducted with an initial denaturing step of 3 minutes at 94°C, followed by 35 cycles of 94°C for 10 seconds, 58°C for 15 seconds and 72°C for 20 seconds, with a final extension at 72°C for 7 minutes. Mouse c-Maf mRNA expression was normalized to the levels of the GAPDH gene. Relative fold differences were determined using the method of delta-delta CT, calculated as 2−( Ct Target gene − Ct GAPDH ). All experiments were performed at least three separate times.
| Western blot analyses
Whole-cell lysates were prepared for Western blotting. Protein concentrations were determined using the BCA Protein Assay Kit (Cat. No. 23227, Pierce, USA). Twenty-five micrograms of cell protein was electrophoretically separated on a 12% SDS-polyacrylamide gel and transferred to a PVDF membrane, which was then blocked by incubation for 1 hour at room temperature in 5% fat-free dry milk in Tris-buffered saline containing 0.1% Tween 20 (TBS-T). The blots were then incubated overnight at 4°C with rabbit antibodies against mouse β-actin (#4970, Cell Signaling Technology, Danvers, MA, USA) and c-Maf (#79737, Cell Signaling Technology) diluted 1:1000 in TBS-T containing 5% bovine serum albumin, washed for 30 min with TBS-T and incubated for 1 hr at room temperature with horseradish peroxidase-conjugated goat anti-rabbit IgG (H+L) (GGHL-90P, Immunology Consultants Laboratory, Newberg, OR, USA) (1:5000 in TBS-T containing 5% bovine serum albumin); then, bound antibody was visualized using the ECL detection system (Amersham, Arlington Heights, IL, USA). All experiments were performed at least three separate times.
| Knockdown of c-Maf in B cells
B220
+ B cells (1 × 10 6 cells/mL) were infected with 1 mL 1 × 10 7 IU (infected units) control and c-Maf-specific short hairpin RNA (shRNA)-contained lentivirus (sc-145222-V; Santa Cruz Biotech, CA, USA) in the presence of 1 μg/mL LPS in six-well plates (total volume: 4 mL) in RPMI-1640 medium containing 10% foetal bovine serum, 2 mmol/L glutamine, penicillin (100 IU/mL), streptomycin (100 mg/mL) and 50 mmol/L 2-mercaptoethanol. On day 3, cells were collected, and lysates were analysed by qPCR and Western blot.
| IL-10 concentration analysis by ELISA
B220 + B cells from 7-to 9-week-old C57BL/6 mice were sorted by B220 microbeads and cultured in vitro for different times in the presence of 1 μg/mL LPS. The concentration of IL-10 in the supernatant was measured by ELISA (Cat#BMS614/2*, eBioscience). Briefly, antimouse IL-10 capture antibody was coated in triplicate to the plate overnight at 4°C, and diluted supernatants were added to the plate for 1 hour at 37°C. After washing, 4 μg/mL biotin rat anti-mouse IL-10 detection antibody was added to the plate, and the solution was incubated for 1 hour at 37°C. Thereafter, unbound antibodies were washed off, followed by the addition of avidin-horseradish peroxidase (1/1000 diluted). Plates were incubated for 1 hour at 37°C. Finally, the colour was developed by incubation with o-phenylenediamine. The optical density was read at 492 nm with an ELISA reader (Bio-Rad). Standard curves were established to quantify the amounts of the respective cytokines. All experiments were performed at least three separate times.
| ChIP assay
B cells were treated with LPS (1 μg/mL) for 12 hour, and then, ChIP assays were performed. Chromatin was immunoprecipitated according to the manufacturer's instructions (#9002, Cell Signaling Technology). Briefly, sorted cells were cross-linked with 1% (vol/vol) formaldehyde at room temperature for 10 minutes and incubated with glycine for 5 min at room temperature. Cells were then sequentially washed in ice-cold buffer A and buffer B, followed by digesting with MNase. The nuclear pellet was suspended in ChIP buffer and sheared by sonication, with an average size of sheared fragments of approximately 300-800 bp. After centrifugation at 9600 g for 10 minutes, sheared chromatin was diluted in ChIP buffer and precleared by addition of protein A/G plus agarose beads (sc-2003, Santa Cruz Biotech) for 1 hour at 4°C. Before antibody incubation, input samples were removed from the lysate and stored at 80°C until extraction. The beads were discarded, and the supernatant was then incubated with anti-mouse c-Maf antibody (#79737, Cell Signaling Technology) or control anti-IgG (Cell Signaling Technology) at 4°C overnight. The next day, protein A/G plus agarose beads were added and incubated for 2 hours at 4°C. The beads were harvested by centrifugation and went through three low-salt washes and one high-salt wash. The beads were then treated with ChIP elution buffer. The eluates and input were then added to proteinase K and RNase A and heated at 65°C for 2 hours to reverse the formaldehyde cross-link. The DNA fragments were purified with ChIP DNA Clean & Concentrator TM-capped columns (D5205, Zymo Research Corp, Irvine, CA, USA). The immunoprecipitated and input DNA, and A SYBR Green PCR Kit (Bio-Rad, Hercules, CA, USA), were used for quantitative real-time PCR analysis. The primers used were as follows: IL-10 MARE, CTC TCC TCT GAC CAA CTG CC and TGG GTT GAA CGT CCG ATA TT. PCR was conducted with an initial denaturing step of 3 minutes at 94°C, followed by 45 cycles of 94°C for 10 seconds, 60°C for 15 seconds and 72°C for 10 seconds, with a final extension at 72°C for 7 minutes. The results were quantified with an Icycler IQ iCycler iQ (Bio-Rad). The relative binding was defined by determining the immunoprecipitation level (ratio of the amount of immunoprecipitated DNA to that of the input sample). All experiments were performed at least three separate times.
| Statistics
Statistical comparisons were assessed by Student's t test.
All P values were derived from a two-tailed statistical test using SPSS 11.5 software (SPSS Inc. Chicago). A P-value of <0.05 was considered statistically significant. The results were always represented as a mean (of at least three different assays) ±SD.
| RESULTS
| c-Maf expression was upregulated in LPS-stimulated B cells
To 
| c-Maf directly bound to the IL-10 promoter in B cells
It was reported that c-Maf directly transactivated IL-10 gene expression by binding to a MARE motif in the IL-10 promoter. 12 To our knowledge, there are no data about the regulation of c-Maf on the activation of IL-10 in B cells. ChIP-PCR technology was used to address this question The sequence of IL-10 MARE is shown in Figure 1E . To perform ChIP, B220 microbeads were employed to sort B220 + B cells from 7-to 9-week-old C57BL/6 mice, and 
| c-Maf expression was positively associated with IL-10 expression in B cells from CIA mice
Previous research has shown the defective development or function of Breg cells in autoimmune diseases such as arthritis. We successfully established the arthritis model by collagen II injection ( Figure 3A,B) . HE staining showed significantly aggravated joint damage in CIA mice compared to that in control mice ( Figure 3A) . At day 35, the articular index of almost all of the CIA mice reached 12 ( Figure 3B ). Compared with control mice, CIA-induced arthritis mice had a lower frequency IL-10 + Breg cells both in the spleen and lymph nodes (P < 0.05, Figure 3C,D) . Critically, we found that c-Maf expression decreased in B cells from CIA mice ( Figure 3E ). These results suggest that c-Maf expression was positively associated with IL-10 expression in B cells from CIA-induced arthritis mice ( Figure 3C-E) . c-Maf cooperates with AhR in the regulation of IL-10 production in mice as well as humans. 22 In the presence of LPS, the expression of c-Maf improved markedly in B cells and was followed by increased production of IL-10. It is necessary to explore whether there are other specific inducers of IL-10 production in B cells. Extensive studies showed that regulatory B cell subsets could suppress disease symptoms in experimental autoimmune encephalitis (EAE), 23 collagen-induced arthritis 24 and lupus mouse models. 25 Zheng reported that the frequency of In conclusion, we found that, when activated in vitro and in vivo, B cells upregulated c-Maf expression. Critically, c-Maf knockdown effectively downregulated IL-10 + Breg cells. The relationship between c-Maf expression and IL-10 + Breg cells was further proved in CIA mice. We identified c-Maf as a critical node involved in IL-10 production from B cells. We provided a novel molecular mechanism for the regulation of autoimmune disease, infectious diseases and tumours by Breg cells.
